Creatine Kinase Elevation in Patients with Autosomal Dominant Polycystic Kidney Disease on Tolvaptan Treatment

被引：0
|
作者：
Rodriguez-Espinosa, Diana [1 ]
Payan, Elena C. [1 ]
Guillen, Elena [1 ]
Blasco Pelicano, Josep Miquel [1 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO1205
引用
收藏
页码：393 / 393
页数：1
相关论文
共 50 条
  • [1] Creatine Kinase Elevation in Autosomal Dominant Polycystic Kidney Disease Patients on Tolvaptan Treatment
    Rodriguez-Espinosa, Diana
    Jesus Broseta, Jose
    Bastida, Carla
    Isabel Alvarez-Mora, Maria
    Nicolau, Carlos
    Alvarez, Cristina
    Agraz-Pamplona, Irene
    Sanchez-Baya, Maya
    Furlano, Monica
    Ruiz, Cesar
    Quintana, Luis F.
    Pineiro, Gaston J.
    Poch, Esteban
    Torra-Balcells, Roser
    Blasco, Miquel
    NEPHRON, 2023, 147 (3-4) : 152 - 157
  • [2] CREATINE-KINASE ELEVATION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE PATIENTS ON TOLVAPTAN TREATMENT
    Rodriguez Espinosa, Diana
    Broseta Monzo, Jose Jesus
    Cuadrado, Elena
    Quintana Porras, Luis Fernando
    Poch, Esteban
    Pineiro, Gaston
    Agraz, Irene
    Sanchez-Baya, Maya
    Furlano, Monica
    Ruiz, Cesar
    Torra, Roser
    Blasco, Miquel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I5 - I5
  • [3] Case report: tolvaptan-associated creatine kinase elevation in two patients with autosomal dominant polycystic kidney disease (ADPKD)
    Agraz-Pamplona, I.
    Larrosa-Garcia, M.
    Bury-Macias, R. P.
    Seron-Micas, D.
    Montoro-Ronsano, J. B.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (10) : 1473 - 1475
  • [4] Case report: tolvaptan-associated creatine kinase elevation in two patients with autosomal dominant polycystic kidney disease (ADPKD)
    I. Agraz-Pamplona
    M. Larrosa-Garcia
    R. P. Bury-Macias
    D. Serón-Micas
    J. B. Montoro-Ronsano
    European Journal of Clinical Pharmacology, 2020, 76 : 1473 - 1475
  • [5] Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
    Torres, Vicente E.
    Chapman, Arlene B.
    Devuyst, Olivier
    Gansevoort, Ron T.
    Grantham, Jared J.
    Higashihara, Eiji
    Perrone, Ronald D.
    Krasa, Holly B.
    Ouyang, John
    Czerwiec, Frank S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25): : 2407 - 2418
  • [6] Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
    Spital, Aaron
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (13): : 1257 - 1257
  • [7] Tolvaptan and Autosomal Dominant Polycystic Kidney Disease
    Ingelfinger, Julie R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1988 - 1989
  • [8] CLINICAL EFFICACY OF TREATMENT WITH TOLVAPTAN IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Martins Munoz, Judith
    Tarragon, Blanca
    De Lorenzo, Alberto
    Espinel, Laura
    Teresa Naya, Maria
    Cubas, Alfonso
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I13 - I13
  • [9] THE BURDEN OF TOLVAPTAN TREATMENT FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
    Muto, Satoru
    Kawano, Haruna
    Sugiura, Syou-ichiro
    Kitamura, Kousuke
    Kimura, Masaki
    Isotani, Shuji
    Ide, Hisamitsu
    Yamaguchi, Raizo
    Horie, Shigeo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [10] Tolvaptan in Autosomal Dominant Polycystic Kidney Disease Reply
    Torres, Vicente E.
    Gansevoort, Ron T.
    Czerwiec, Frank S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (13): : 1259 - 1259
12345